In the article titled “Argon treatment after experimental subarachnoid hemorrhage: evaluation of microglial activation and neuronal survival as a subanalysis of a randomized controlled animal trial,” published on pages 103–109, Issue 3, Volume 10, 2020 of Medical Gas Research1 (doi: 10.4103/2045-9912.296039), the labels for SAH Ar and SAH N2 groups in Figures 1, 4–6 were incorrectly written as “Sham Ar” and “Sham N2” in the published version. The correct Figures 1, 4–6 are shown below:
Additionally, Figure 3A shows an exemplary brain slice including the regions of interest analyzed. This figure is not a part of the analyzed data but merely an internal laboratory template for precisely defining anatomical locations, ultimately serving quality assurance. Therefore, the title of Figure 3A is corrected as exemplary representation of the anatomical locations analyzed (modified from Veldeman et al.2).
This correction does not change the results, interpretations, or conclusions of the study. The authors apologize for any inconvenience this correction may cause for readers and editors of Medical Gas Research.
Reference
- 1.Kremer B, Coburn M, Weinandy A, et al. Argon treatment after experimental subarachnoid hemorrhage: evaluation of microglial activation and neuronal survival as a subanalysis of a randomized controlled animal trial. Med Gas Res. 2020;10:103–109. doi: 10.4103/2045-9912.296039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Veldeman M, Coburn M, Rossaint R, et al. Xenon reduces neuronal hippocampal damage and alters the pattern of microglial activation after experimental subarachnoid hemorrhage: a randomized controlled animal trial. Front Neurol. 2017;8:511. doi: 10.3389/fneur.2017.00511. [DOI] [PMC free article] [PubMed] [Google Scholar]
